Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS(2) score ⩾ 2

BACKGROUND: The nonvitamin K antagonist oral anticoagulants pivotal clinical trials for stroke prevention in atrial fibrillation have important differences in trial designs and baseline patient characteristics. OBJECTIVE: We sought to evaluate the relative efficacy and safety of edoxaban versus othe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:SAGE Open Med
Päätekijät: Fernandez, Maria M, Wang, Jianmin, Ye, Xin, Kwong, Winghan Jacqueline, Sherif, Bintu, Hogue, Susan, Sherrill, Beth
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2015
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4822531/
https://ncbi.nlm.nih.gov/pubmed/27092254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050312115613350
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia